| December 2008 Working paper, "Applying a Systems Mindset to FDA," is forthcoming in Medical Hypotheses 72 (2009) 116-120. New title: "A Dual Track System to Give More-Rapid Access to New Drugs: Applying a Systems Mindset to the US Food and Drug Administration (FDA)." This article provides a comprehensive argument for the introduction of consumer choice and competition and pinpoints the weakness in the status quo position. | |||||||||||||||||||||||||||||||||||||
| November 2008 Foreward to a new book by David Holland and Tom Larsen, Beyond Earnings: A User's Guide to Excess Return Models and the HOLT CFROI ® Framework September 2008 | "Shareholder Value Reviews" published in Strategic Finance , September 2008. It provides a short and useful overview of the SVR concept. July 2008 | "Applying a Systems Mindset to Stock Valuation" reviews five important choices that guided the development of the life-cycle valuation model over the last 40 years. June 2008 | "Applying a Systems Mindset to FDA" addresses the fundamental weaknesses in the arguments of those supporting the status quo, FDA-controlled access to drugs. May 2008 | "Guidepost to Wealth Creation: Value-Relevant Track Records" was published in the Fall/Winter 2007 issue of the Journal of Applied Finance. January 2008 |
"Economic Rewards of Dual Tracking" November 2007 |
"Presidents, Politics and Creating Wealth" March 2007 |
"More Choices, Better Health - Free To Choose Experimental Drugs" November 2006 November 2006 |
"For Better Corporate Governance, The Shareholder Value Review" was published in the Winter 2007 issue of the Journal of Applied Corporate Finance. December 2005 |
"A Clinical Trial for the FDA's Clinical Trial Process" Published in Cancer Biotherapy & Radiopharmaceuticals September 2005 | Download monograph Maximizing Shareholder Value And The Greater Good. Here is a Book review. Print versions of the monograph can be purchased on Amazon.The CFROI computation used in this monograph is based on more advanced thinking on certain technical issues compared to my 1999 book CFROI Valuation - A Total System Approach to Valuing the Firm. The current CFROI computation excludes acquisition goodwill (see "Will Your Next Acquisition Pay Off?") and capitalizes R&D. The above monograph contains more advanced thinking on certain technical issues compared to my 1999 book CFROI Valuation - A Total System Approach to Valuing The Firm. The current CFROI computation excludes acquisition goodwill (see " Will Your Next Acquisition Pay Off?") and capitalizes R&D
|
March 2005 June 2004 |
"Breaking the FDA Monopoly" Regulation, Summer, 2004 January 1990 |
"A Transactional Approach to Economic Research" A slightly modified version of this paper was published in The Journal of Socio-Economics, 1991, Vol. 20, No. 1, 57-71. My intention is to post articles written after I retired in November 2003. One exception is this piece since, in my opinion, it is a very useful summary of the transactional knowing process that is foundational to all of my work. |
|
|
|
| ||||||||||||||||||||